|
| ||||||||||||||
MAKO Surgical Corp. to Present At the 2008 Morgan Stanley Global Healthcare Unplugged Conference FORT LAUDERDALE, Fla., April 23, 2008 (PRIME NEWSWIRE) --
MAKO Surgical Corp. (NasdaqGM:MAKO - News) announced today that Maurice
R. Ferre, M.D., its President and Chief Executive Officer,
and Fritz L. LaPorte, its Senior Vice President and Chief
Financial Officer, are scheduled to present at the 2008
Morgan Stanley Global Healthcare Unplugged Conference on
Wednesday, April 30, 2008, at 11:10 a.m. The conference
will be held at the Ritz-Carlton in Key Biscayne, Florida. About MAKO Surgical Corp. MAKO Surgical Corp. is a medical device company that markets its advanced robotic arm solution and implants for minimally invasive orthopedic knee procedures. The MAKO Tactile Guidance System(tm) (TGS(tm)) includes a surgeon-interactive tactile robotic arm platform that utilizes a robotic arm and patient-specific visualization to prepare the knee joint for the insertion and alignment of resurfacing implants through a minimal incision. This FDA-cleared TGS allows surgeons to provide a tissue-sparing, bone resurfacing procedure called MAKOplasty(r) to a large, yet underserved patient-specific population suffering from early to mid-stage osteoarthritic knee disease. MAKO has an intellectual property portfolio of more than 200 licensed or owned patents and patent applications relating to the areas of computer assisted surgery, haptics, robotics and implants. Additional information can be found at http://www.makosurgical.com. Contact: MAKO Surgical Corp.
Investors:
Susan M. Verde
954-927-2044 x349
sverde@makosurgical.com
Westwicke Partners
Mark Klausner
410-321-9650
mark.klausner@westwickepartners.com
Source: MAKO Surgical Corp
| ||||||||||||||